Emergence and rapid dissemination of highly resistant NDM-14-producing Klebsiella pneumoniae ST147, France, 2022

  24 October 2023

Carbapenems remain one of the last-line options to treat infections caused by highly resistant Enterobacterales, but production of carbapenemase enzymes is one of the main resistance mechanisms to carbapenems in these bacteria. Accordingly, the increasing dissemination of carbapenemase-producing Enterobacterales (CPEs) poses a global threat to public health. 

The recent and rapid emergence of NDM-14-producing  ST147 isolated from patients in France directly repatriated from Morocco suggests a spread of this clone particularly in the Casablanca region. This clone likely emerged recently from an endemic NDM-1-producing  ST147.

Further reading: EuroSurveillance
Author(s): Cécile Emeraud et al
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed